| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.37 | 0.008 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.4 | 0.008 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |